All News

On social media, CURE® recently asked its readers what their thoughts were on the medical use of cannabis. Here, we share some of their responses.

A roundup of the latest news and updates for patients with acute myeloid leukemia from CURE®.

CURE® compiled a roundup of five recent reports patients with lymphoma may have missed.

Arzerra will be available at no cost to patients via an oncology patient access program which will be facilitated through Patient Access Novartis Oncology.

Chadwick Boseman, known best for his role in “Black Panther,” has died after receiving a colon cancer diagnosis four years ago.

Eryaspase, a novel drug candidate, is being evaluated in patients with second-line metastatic pancreatic cancer and those with metastatic triple-negative breast cancer.

Nearly half (48%) of the patients reported experiencing significant fatigue following their surgery. Thirty-nine percent of the patients still reported significant fatigue one year following their surgery.

In addition to improving progression-free survival, researchers have found single-agent Ninlaro (ixazomib) to be a tolerable option in patients with newly diagnosed multiple myeloma who have also already undergone an autologous stem cell transplant.

The novel next-generation ALK tyrosine kinase inhibitor improved survival, compared with Xalkori, in patients with ALK-positive non-small cell lung cancer, potentially representing a new option in the first-line setting.

I am not pining for the end of the pandemic, which makes me a bit of a weirdo among people I know, even though the end of the pandemic would be wonderful. I have been changed as a result of my cancer diagnosis, for it taught me that things can change at any moment.

The test was also approved as a companion diagnostic test to determine which select patients with metastatic castration-resistant prostate cancer could benefit from Rubraca, as well as for three frontline TKIs in patients with non-small cell lung cancer.

Here is a list of the recent trial initiations that occurred within the cancer space in August.

Often uncovered by accident, appendiceal cancers trigger few symptoms until they’re advanced and can be difficult to detect and treat.

I confronted my oncologist and dentist about the research I found. After doing their own research, they told me that cancer and treatment can weaken bone structure including teeth. I wish I had been told this earlier.

The Food and Drug Administration noted the trial design was acceptable for researchers to evaluate VERU-111 in in metastatic castration and novel androgen-blocking agent resistant prostate cancer.

The FDA has approved a generic form of the intravenous chemotherapy pemetrexed for use by itself in patients with locally advanced or metastatic non-squamous non-small cell lung cancer that has not progressed following four cycles of initial platinum-based chemotherapy.

The agent, in combination with the current standard of care, is being evaluated as a frontline treatment for patients with high-risk Denovo Genomic Marker 1 (DGM1)–positive DLBCL.

“Through patients’ eyes, augmented intelligence may improve health care quality but should be implemented in a manner that preserves the integrity of the human physician-patient relationship,” the authors wrote.

At a median follow-up of 10 months, all patients who received Tafinlar plus Mekinist achieved an overall response rate of 51%.

On social media, CURE® recently asked its readers to share some tips for others for coping with roadblocks they might experience on their cancer journey. Here, we share some of their responses.

Dr. Jennifer L. Atlas notes that while these results could lead to a paradigm shift, surgery and radiation aren’t being eliminated as treatment options.

Could paradigm shifts in cancer research help find a cure for cholangiocarcinoma? Experts discuss.

After lifesaving medicine became available to treat hepatitis C virus, a risk factor for liver cancer, racial inequities in the death rate from the malignancy began a steady upward climb.

From the bi-partisan Research to Accelerate Cures and Equity (RACE) for Children Act implementing an FDA mandate that all new cancer therapies for adults must also be studied in children, to the “Iron Man” of baseball Cal Ripken Jr. announcing he’s cancer free after a February diagnosis, here’s what’s happening in the cancer landscape this week.

Specific measures of a tumor’s texture and intensity as they appear on CT images can help determine how much treatment patients with early stage lung cancer need, a study found.

The Food and Drug Administration (FDA) has approved the expansion of Kyprolis (carfilzomib) in combination to with Darzalex (daratumumab) plus dexamethasone in once- and twice-weekly dosing regimens for the treatment of patients with relapsed or refractory multiple myeloma who have received a maximum of three prior lines of therapy.